跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 104 条关于
“NPR1”
全部
104
临床试验
52
药物
29
机构
0
资讯
23
3个月前
Regeneron Advances Two Major Clinical Programs in Critical Care and Cardiovascular Disease
8个月前
Regeneron Advances REGN9533 Blood Clot Treatment Through Phase 1 While Terminating Heart Failure Program
6个月前
Self-Amplifying RNA Therapy Shows Promise for Heart Attack Recovery in Preclinical Studies
去年
Revumenib Shows Promise in Relapsed/Refractory NPM1-Mutated AML
去年
p62 and NBR1 Levels Predict Immunotherapy Response in Liver Cancer
去年
Revumenib Shows Promise in NPM1-Mutant AML: Pivotal Trial Results
去年
Ziftomenib Plus Intensive Induction Shows Promise in NPM1-Mutated AML
去年
FDA Extends Review of Zenocutuzumab for NRG1+ NSCLC and Pancreatic Cancer
10个月前
FDA Approves Kura Oncology's Komzifti for NPM1-Mutated AML with Competitive Safety Advantage
去年
Bleximenib Shows Promising Results in Advanced Acute Leukemia Trial with KMT2A and NPM1 Mutations
第 1 页,共 3 页
上一页
下一页